Common questions about Twirla (FAQ)
Q: How is Twirla different from other contraceptive patches?
A: Twirla is classified as a combined hormonal patch, utilizing the synthetic hormones Levonorgestrel and Ethinyl Estradiol. A key distinction, noted in the official prescribing information, is that Twirla delivers a lower daily dose of Ethinyl Estradiol (estrogen component) compared to certain other transdermal contraceptive systems that have been established for longer periods.
Q: Does Twirla change the timing or heaviness of a period?
A: Official information indicates that women using the patch may experience changes to their menstrual patterns, which can include unscheduled bleeding or spotting outside of the scheduled patch-free week. Additionally, painful periods, known as dysmenorrhea, were reported as a common adverse reaction during clinical studies for the product.
Q: Will I have a period every month while using Twirla?
A: The Twirla regimen is structured to allow for withdrawal bleeding (similar to a period) during the patch-free week each month. However, official labeling notes that some users may experience amenorrhea, which is the complete absence of scheduled bleeding. If scheduled bleeding is missed, the possibility of pregnancy may need to be assessed.
Q: How does the patch stick if I shower or swim often?
A: Patient instructions advise checking the patch every day to ensure it is firmly in place. This includes checking the patch after water exposure, such as bathing, showering, or swimming. The manufacturer describes the patch as having features designed for sustained adhesion. Users are advised to check the patch daily to ensure it remains fully attached, especially after water exposure.
Q: What should I do if my Twirla patch falls off before the change day?
A: Regulatory instructions describe the steps to follow if the patch begins to lift or falls off, which includes attempting to put it back on immediately. If the original patch will not stick, a new patch should be applied right away. If the patch has been off for 24 hours or more during an active week, a new 4-week cycle must be initiated, and a non-hormonal backup method is required for the first seven days of the new cycle.
Q: What happens if I forget to change my Twirla patch exactly on time?
A: If the delay in changing the patch in the middle of a cycle (Active Week 2 or 3) is less than 48 hours, a new patch should be applied immediately, and the schedule can revert to the original Patch Change Day. However, if the delay is 48 hours or more, a new 4-week cycle must be started, and a backup contraceptive method must be used for the next seven days of use.
Q: How long does it usually take for Twirla to start working?
A: The onset of contraceptive protection depends on when the patch is started relative to the menstrual cycle. If the first patch is applied within the first 24 hours of the start of a menstrual period, contraceptive protection is generally established immediately. If the patch is started at any other time, a non-hormonal backup contraceptive method must be used for the first seven days of the initial cycle.
Q: Does Twirla cause changes in mood in some users?
A: While not always listed among the most common adverse reactions, official documentation recognizes that combined hormonal contraceptives may be associated with mood changes. These can include mood swings, depression, or emotional lability.
Q: If I stop using Twirla, how long until my cycle returns to normal?
A: Following the discontinuation of combined hormonal contraceptives, official guidance indicates that the return to a regular menstrual cycle and typical reproductive function is generally expected to occur quickly after the hormones have cleared the system.
Q: What kind of research evidence supports the use of Twirla?
A: The approval for Twirla is supported by evidence from a large Phase 3 clinical trial known as the SECURE study, where participants were observed for one year. The official regulatory data reported an overall Pearl Index of 5.8 (with a 95% Confidence Interval of 4.5–7.2), which is a calculation used by researchers to measure the rate of pregnancy per 100 women using the method for a year.
Q: Are the hormone levels from Twirla stable throughout the week?
A: The Twirla transdermal system is specifically engineered to provide a continuous, stable daily nominal dose of Levonorgestrel and Ethinyl Estradiol. Pharmacokinetic studies examined the way the body handles the medicine to ensure systemic hormone exposure over the full seven days of wear.
Q: What are the typical instructions for stopping Twirla use?
A: Official documentation specifies that the patch must be discontinued well in advance of major surgery or prolonged immobilization. For elective stopping, if pregnancy is to be avoided, a non-hormonal backup contraceptive method must be immediately implemented upon discontinuation, and consulting a healthcare provider is generally advised.
Q: Can I get pregnant if the patch is off for a short time?
A: Official regulatory instructions indicate that if a patch is off for less than 24 hours, the user should put it back on or replace it with a new patch, and no backup contraception is required. Protection is considered reduced if the patch is off for longer periods than this, as described in the instructions for missed dosing.
Q: What is the difference between Twirla and Xulane?
A: Twirla and Xulane are both transdermal contraceptive patches, but they contain different hormones and doses. Twirla contains Levonorgestrel and 30 mcg of Ethinyl Estradiol. Xulane contains Norelgestromin and 35 mcg of Ethinyl Estradiol. Twirla's 30 mcg of Ethinyl Estradiol is a lower dose than the 35 mcg found in Xulane.
Q: How is the hormone released from the Twirla patch?
A: Twirla functions as a transdermal system that utilizes an adhesive matrix containing the active ingredients. This system is designed to release its hormonal components—Levonorgestrel and Ethinyl Estradiol—continuously through the skin and directly into the bloodstream over the course of the one-week application period.
Q: Is it common to have spotting or breakthrough bleeding on Twirla?
A: Yes, unscheduled bleeding and spotting are common occurrences for women using the transdermal patch. Regulatory data indicates this is particularly frequent during the first few months of use, but it typically tends to lessen or resolve as the user continues on the prescribed schedule.
Q: Are the side effects of Twirla permanent?
A: While the regulatory information does not specifically address the term 'permanent,' side effects observed in clinical trials are generally considered transient and expected to resolve after the drug is discontinued. Official safety information recognizes that rare, serious adverse events, such as certain cardiovascular events, are associated with combined hormonal contraceptives.
Q: Does Twirla cause changes in appetite?
A: Weight gain was reported as a common adverse reaction in clinical trials for Twirla. Although changes in appetite are not listed as a separate frequent adverse event, this is a related topic. Official labeling provides detailed information on all recognized adverse effects.
Q: How is Twirla disposed of after use?
A: Official regulatory instructions require a specific disposal protocol for used patches. The patch must first be folded in half so that the adhesive sides stick together, neutralizing any remaining active medicine. The folded system must then be safely discarded in the trash. Disposal instructions prohibit flushing the used patch down the toilet.
Q: Is it possible to use Twirla while breastfeeding?
A: Official documentation advises that combined hormonal contraceptives, including the Twirla patch, may lead to a reduction in the quantity and quality of milk produced in women who are breastfeeding. Therefore, the patch is generally not recommended for use while breastfeeding, and an alternative method of contraception may be discussed.
